Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

Summary

The purpose of the study is to assess the efficacy and safety of NGX-4010 applied for 60 minutes for the treatment of postherpetic neuralgia (PHN).

Timeline

Start

2006-03

Primary completion

—

Completion

2007-08

Outcome

Met primary endpoint

paper NGX-4010 recipients had a significantly greater mean reduction from baseline in pain during weeks 2-8 compared with the control group (32.0% vs 24.4%; P=0.011). PMID 21087403 ↗

Publications

• Irving GA, Backonja MM, Dunteman E, Blonsky ER, Vanhove GF, Lu SP, Tobias J; NGX-4010 C117 Study Group. A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. Pain Med. 2011 Jan;12(1):99-109. doi: 10.1111/j.1526-4637.2010.01004.x. Epub 2010 Nov 18.

Drugs

Indications